Bridgefront Capital’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,709
Closed -$204K 732
2024
Q2
$204K Buy
+15,709
New +$204K 0.09% 411